Novel CCR5 antagonists for the treatment of HIV infection: a review of compounds patented in 2006 - 2008.
about
The CD8-derived chemokine XCL1/lymphotactin is a conformation-dependent, broad-spectrum inhibitor of HIV-1.Allosteric modulation of purine and pyrimidine receptors.Investigation of mechanism of drug-induced cardiac injury and torsades de pointes in cynomolgus monkeys.Small molecule HIV entry inhibitors: Part I. Chemokine receptor antagonists: 2004 - 2010.
P2860
Novel CCR5 antagonists for the treatment of HIV infection: a review of compounds patented in 2006 - 2008.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel CCR5 antagonists for the ...... ounds patented in 2006 - 2008.
@en
Novel CCR5 antagonists for the ...... ounds patented in 2006 - 2008.
@nl
type
label
Novel CCR5 antagonists for the ...... ounds patented in 2006 - 2008.
@en
Novel CCR5 antagonists for the ...... ounds patented in 2006 - 2008.
@nl
prefLabel
Novel CCR5 antagonists for the ...... ounds patented in 2006 - 2008.
@en
Novel CCR5 antagonists for the ...... ounds patented in 2006 - 2008.
@nl
P2860
P1476
Novel CCR5 antagonists for the ...... ounds patented in 2006 - 2008.
@en
P2093
David M Rotstein
Hanbiao Yang
P2860
P304
P356
10.1517/13543770903575674
P407
P577
2010-03-01T00:00:00Z